Diffusion and perfusion MRI parameters in the evaluation of placenta accreta spectrum disorders in patients with placenta previa

被引:6
|
作者
Lu, Tao [1 ]
Wang, Yishuang [1 ]
Deng, Yan [1 ]
Wu, Chengqian [1 ]
Li, Xiangqi [1 ]
Wang, Guotai [2 ]
机构
[1] Univ Elect Sci & Technol China, Sichuan Prov Peoples Hosp, Dept Radiol, 32 West Second Sect,First Ring Rd, Chengdu 610072, Peoples R China
[2] Univ Elect Sci & Technol China, Sch Mech & Elect Engn, West Hitech Zone, 2006 Xiyuan Ave, Chengdu 611731, Peoples R China
关键词
Placenta accreta spectrum disorders; Diffusion-weighted MRI; Intravoxel incoherent motion; Diffusion kurtosis imaging; KURTOSIS; PREGNANCY;
D O I
10.1007/s10334-022-01023-5
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Objectives To evaluate the placental function by monoexponential, biexponential, and diffusion kurtosis MR imaging (MRI) in patients with placenta previa. Methods A total of 62 patients with placenta accreta spectrum (PAS) disorders and 11 patients with normal placentas were retrospectively enrolled, who underwent conventional diffusion-weighted imaging (DWI), intravoxel incoherent motion (IVIM), and diffusion kurtosis imaging (DKI). The apparent diffusion coefficient (ADC) and exponential ADC (eADC) from standard DWI, mean kurtosis (MK), and diffusion coefficient (MD) from DKI, and pure diffusion coefficient (D), pseudo-diffusion coefficient (D*), and perfusion fraction (f) from IVIM were measured and compared from the volumetric analysis. Results Comparisons between patients with PAS disorders and patients with normal placentas demonstrated that MD mean, D mean, and D* mean values in patients with PAS disorders were significantly higher than those in patients with normal placentas (p < 0.05). Comparisons between patients with accreta, increta, and percreta, and patients with normal placentas showed that the D mean was significantly higher in patients with placenta increta and percreta than in patients with normal placentas (p < 0.05). Conclusion The accreta lesions in PAS disorders had deceased cellularity and increased blood movement. The alteration of placental cellularity was more prominent in placenta increta and percreta.
引用
收藏
页码:1009 / 1020
页数:12
相关论文
共 50 条
  • [41] Evaluation of the Tramline Sign in the Prediction of Placenta Accreta Spectrum and Perioperative Outcomes in Anterior Placenta Previa
    Dall'Asta, Andrea
    Forlani, Francesco
    Shah, Harsha
    Paramasivam, Gowrishankar
    Yazbek, Joseph
    Bourne, Tom
    Cali, Giuseppe
    Lees, Christoph
    ULTRASCHALL IN DER MEDIZIN, 2022, 43 (06): : e118 - e124
  • [42] Risk factors and morbidity in patients with placenta previa accreta compared to placenta previa non-accreta
    Zaki, ZMS
    Bahar, AM
    Ali, ME
    Albar, HAM
    Gerais, MA
    ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 1998, 77 (04) : 391 - 394
  • [43] Abnormal Placentation Placenta Previa, Vasa Previa, and Placenta Accreta
    Silver, Robert M.
    OBSTETRICS AND GYNECOLOGY, 2015, 126 (03): : 654 - 668
  • [44] PLACENTA ACCRETA - WITH SPECIAL REFERENCE TO COMBINED PLACENTA PREVIA AND ACCRETA
    DIMASI, FT
    MCGOLDRICK, DM
    GROGAN, RH
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1963, 87 (02) : 190 - &
  • [45] SIMULTANEOUSLY OCCURRING PLACENTA PREVIA AND PLACENTA ACCRETA
    KISTNER, RW
    HERTIG, AT
    REID, DE
    SURGERY GYNECOLOGY & OBSTETRICS, 1952, 94 (02): : 141 - 151
  • [46] PLACENTA ACCRETA, PERCRETA AND PREVIA ACCRETA
    KITCHEN, DH
    AUSTRALIAN & NEW ZEALAND JOURNAL OF OBSTETRICS & GYNAECOLOGY, 1978, 18 (04): : 238 - 241
  • [47] Association of Placenta Previa With Severe Maternal Morbidity Among Patients With Placenta Accreta Spectrum Disorder
    Han, Xueyan
    Guo, Zhirong
    Yang, Xinrui
    Yang, Huixia
    Ma, Jingmei
    JAMA NETWORK OPEN, 2022, 5 (08) : e2228002
  • [48] Risk factors and clinical outcomes for placenta accreta spectrum with or without placenta previa
    Ogawa, Kohei
    Jwa, Seung Chik
    Morisaki, Naho
    Sago, Haruhiko
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2022, 305 (03) : 607 - 615
  • [49] Risk factors and clinical outcomes for placenta accreta spectrum with or without placenta previa
    Kohei Ogawa
    Seung Chik Jwa
    Naho Morisaki
    Haruhiko Sago
    Archives of Gynecology and Obstetrics, 2022, 305 : 607 - 615
  • [50] Effectiveness of Intrauterine Bakri Balloon® Tamponade for Placenta Previa and Placenta Accreta Spectrum
    Ozgen, Gulten
    Aydin, Gultekin Adanas
    JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 2020, 30 (07): : 707 - 712